date:Jan 22, 2014
Biotechnology company Novozymes has reported that all financial targets were met or exceeded for 2013 following a good fourth quarter. Organic sales growth was 7% (5% DKK, 8% LCY), EBIT grew by 6% and net profit by 9%, and the EBIT margin increased by 0.3 percentage point to 24.7% compared with 2012.
2014 is expected to show a continuation of trends seen in 2013, the company said. As a result, the outlook for 2014 is positive with good underlying sales and EBIT growth. The outlook includes the